Mutation detail:
Mutation site | S143G/A197T |
Virus | Influenzavirus A H1N1 |
Mutation level ![]() |
Amino acid Level |
Gene/protein/region type | HA |
Gene ID | 23308115 |
Country | - |
Mutation type ![]() |
nonsynonymous mutation |
Genotype/subtype/clade | - |
Sample ![]() |
Human |
Variants | - |
Viral reference sequence | NC_026433.1 |
Drug/antibody/vaccine | - |
Transmissibility ![]() |
- |
Transmission mechanism | - |
Pathogenicity ![]() |
- |
Pathogenicity mechanism | - |
Immune escape mutation | - |
Immune escape mechanism | - |
RT-PCR primers probes | - |
Protein detail:
Protein name | Hemagglutinin |
Uniprot protein ID | C3W627 |
Protein length | 566 amino acids |
Protein description | The HA protein is translated as an uncleaved HA0 precursor protein, folded as a trimer, and glycosylated and acylated. The HA protein binds to sialic acid-containing receptors on the cell surface, bringing about the attachment of the virus particle to the cell. This attachment induces virion internalization either through clathrin-dependent endocytosis or through clathrin- and caveolin-independent pathway. Plays a major role in the determination of host range restriction and virulence. Class I viral fusion protein. Responsible for penetration of the virus into the cell cytoplasm by mediating the fusion of the membrane of the endocytosed virus particle with the endosomal membrane. Low pH in endosomes induces an irreversible conformational change in HA2, releasing the fusion hydrophobic peptide. Several trimers are required to form a competent fusion pore. |
Literature information:
Pubmed ID | 30429836 |
Clinical information | No |
Disease | - |
Published year | 2018 |
Journal | Frontiers in microbiology |
Title | Seasonal Genetic Drift of Human Influenza A Virus Quasispecies Revealed by Deep Sequencing |
Author | Cyril Barbezange,Louis Jones,Herve Blanc,Ofer Isakov,Gershon Celniker |
Evidence | Thus, for pH1N1, mutations A134T/S183P in the HA and Q313R/V394I in the NA, that we identified as minority mutations during the 2010-2011 season, were used the following season by WHO Collaborating Centers (Barr et al., 2014) to define group 3 sequences (represented by A/Hong-Kong/3934/2011). Similarly, mutations S143G/A197T in the HA and N44S in the NA were used to define group 7 sequences (represented by A/St-Petersburg/100/2011). |